GlobalData tracks 150 drugs in development for Gastroesophageal (GE) Junction Carcinomas by 115 companies/universities/institutes. The top development phase for Gastroesophageal (GE) Junction Carcinomas is phase ii, with 72 drugs in that stage.
Source link
#Gastroesophageal #Junction #Carcinomas #drugs #development
